<table border="1"><tr><th>regular name</th><td><ul><li>2,2-dichloro-n- [1,3-dihydroxy-1- (4-nitrophenyl) ProPan-2-yl] Acetamide</li></ul></td></tr><tr><th>Treats</th><td><ul><li>Infectious Diseases</li></ul></td></tr><tr><th>Ashp | Drugs.com</th><td><ul><li></li></ul></td></tr><tr><th>Medialine Plus</th><td><ul><li>A608008</li></ul></td></tr><tr><th>Legal Mode</th><td><ul><li>Food and Drug Administration: link</li></ul></td></tr><tr><th>Safety Category during pregnancy</th><td><ul><li>a | (Australia) | C | (USA)</li></ul></td></tr><tr><th>Methods of giving the medicine</th><td><ul><li>local medicine (Ocular), Oral, intravenous treatment, muscle injection</li></ul></td></tr><tr><th>Vital availability</th><td><ul><li>75-90%</li></ul></td></tr><tr><th>Protein link</th><td><ul><li>60%</li></ul></td></tr><tr><th>metabolism (metabolism) medicine</th><td><ul><li>liver</li></ul></td></tr><tr><th>Omar Al-Nashaf Al-Bi Half</th><td><ul><li>1.6-3.3 Hours</li></ul></td></tr><tr><th>Directed by (Selja)</th><td><ul><li>Renal (5-15%), faeces (4%)</li></ul></td></tr><tr><th>cas</th><td><ul><li>56-75-7</li></ul></td></tr><tr><th>K</th><td><ul><li>D06D06AX02 Ax02 D10AF03 (| WHO |) G01AA05 (| Who |) J01BA01 (| Who |) S01AA01 (| Who |) S02AA01 (| WHO |) S03AA08(| Who |) Q51BA01 (| Who |)</li></ul></td></tr><tr><th>Bob Kim</th><td><ul><li>CID 298</li></ul></td></tr><tr><th>Echa Infocard ID</th><td><ul><li>100,000.262</li></ul></td></tr><tr><th>Driving Bank</th><td><ul><li>db00446</li></ul></td></tr><tr><th>Kim Spider</th><td><ul><li>5744</li></ul></td></tr><tr><th>The unique component</th><td><ul><li>66974fr9q1</li></ul></td></tr><tr><th>Kyoto</th><td><ul><li>d00104</li></ul></td></tr><tr><th>Chebi</th><td><ul><li>Chebi: 17698</li></ul></td></tr><tr><th>Cheml</th><td><ul><li>Cheml130</li></ul></td></tr><tr><th>Chemical formula</th><td><ul><li>c | 11 | h | 12 | CL | 2 | 2 | O | 5</li></ul></td></tr><tr><th>Molecular Bloc</th><td><ul><li>323.1320 G/Mol</li></ul></td></tr></table>